BlackRock’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$518M Buy
15,677,867
+114,089
+0.7% +$3.77M 0.01% 1027
2025
Q1
$626M Buy
15,563,778
+94,400
+0.6% +$3.79M 0.01% 881
2024
Q4
$728M Buy
15,469,378
+216,539
+1% +$10.2M 0.01% 820
2024
Q3
$805M Buy
15,252,839
+580,060
+4% +$30.6M 0.02% 749
2024
Q2
$795M Buy
14,672,779
+2,258,006
+18% +$122M 0.02% 702
2024
Q1
$870M Sell
12,414,773
-3,687,297
-23% -$259M 0.02% 671
2023
Q4
$1.34B Buy
16,102,070
+467,330
+3% +$39M 0.03% 458
2023
Q3
$461M Buy
15,634,740
+272,567
+2% +$8.03M 0.01% 955
2023
Q2
$501M Buy
15,362,173
+736,791
+5% +$24M 0.01% 935
2023
Q1
$515M Sell
14,625,382
-341,935
-2% -$12M 0.02% 890
2022
Q4
$686M Buy
14,967,317
+397,325
+3% +$18.2M 0.02% 690
2022
Q3
$706M Buy
14,569,992
+1,156,696
+9% +$56M 0.02% 633
2022
Q2
$527M Buy
13,413,296
+348,678
+3% +$13.7M 0.02% 804
2022
Q1
$481M Buy
13,064,618
+113,654
+0.9% +$4.18M 0.01% 1012
2021
Q4
$590M Sell
12,950,964
-311,983
-2% -$14.2M 0.02% 902
2021
Q3
$474M Buy
13,262,947
+1,608,545
+14% +$57.5M 0.01% 1015
2021
Q2
$231M Sell
11,654,402
-273,042
-2% -$5.4M 0.01% 1650
2021
Q1
$277M Buy
11,927,444
+316,365
+3% +$7.36M 0.01% 1468
2020
Q4
$241M Buy
11,611,079
+851,128
+8% +$17.7M 0.01% 1468
2020
Q3
$233M Buy
10,759,951
+1,398,262
+15% +$30.3M 0.01% 1266
2020
Q2
$221M Buy
9,361,689
+236,498
+3% +$5.57M 0.01% 1284
2020
Q1
$108M Sell
9,125,191
-435,411
-5% -$5.13M 0.01% 1585
2019
Q4
$101M Buy
9,560,602
+294,365
+3% +$3.12M ﹤0.01% 1944
2019
Q3
$105M Buy
9,266,237
+207,966
+2% +$2.37M ﹤0.01% 1860
2019
Q2
$102M Buy
9,058,271
+195,445
+2% +$2.2M ﹤0.01% 1888
2019
Q1
$71.7M Buy
8,862,826
+136,255
+2% +$1.1M ﹤0.01% 2069
2018
Q4
$55.2M Buy
8,726,571
+28,184
+0.3% +$178K ﹤0.01% 2175
2018
Q3
$85.7M Buy
8,698,387
+754,593
+9% +$7.43M ﹤0.01% 2051
2018
Q2
$65.9M Buy
7,943,794
+686,537
+9% +$5.7M ﹤0.01% 2190
2018
Q1
$52.3M Buy
7,257,257
+17,863
+0.2% +$129K ﹤0.01% 2232
2017
Q4
$59M Buy
7,239,394
+393,494
+6% +$3.21M ﹤0.01% 2168
2017
Q3
$99.3M Buy
6,845,900
+597,295
+10% +$8.66M 0.01% 1847
2017
Q2
$75.6M Buy
6,248,605
+3,206,723
+105% +$38.8M ﹤0.01% 1972
2017
Q1
$39.1M Buy
3,041,882
+3,038,630
+93,439% +$39M ﹤0.01% 2366
2016
Q4
$40K Buy
3,252
+211
+7% +$2.6K ﹤0.01% 2970
2016
Q3
$28K Buy
3,041
+414
+16% +$3.81K ﹤0.01% 3137
2016
Q2
$24K Buy
2,627
+582
+28% +$5.32K ﹤0.01% 3172
2016
Q1
$15K Sell
2,045
-342
-14% -$2.51K ﹤0.01% 2928
2015
Q4
$25K Sell
2,387
-1,300
-35% -$13.6K ﹤0.01% 2428
2015
Q3
$24K Buy
3,687
+2,900
+368% +$18.9K ﹤0.01% 2250
2015
Q2
$5K Sell
787
-563
-42% -$3.58K ﹤0.01% 3074
2015
Q1
$9K Hold
1,350
﹤0.01% 2743
2014
Q4
$11K Hold
1,350
﹤0.01% 2670
2014
Q3
$5K Buy
1,350
+459
+52% +$1.7K ﹤0.01% 3023
2014
Q2
$4K Hold
891
﹤0.01% 3093
2014
Q1
$8K Buy
891
+205
+30% +$1.84K ﹤0.01% 2827
2013
Q4
$4K Hold
686
﹤0.01% 3053
2013
Q3
$5K Buy
+686
New +$5K ﹤0.01% 2967